KEGG   DRUG: TretinoinHelp
Entry
D00094                      Drug                                   

Name
Tretinoin (JAN/USP/INN);
Avita (TN);
Renova (TN);
Retin A (TN);
Tretinoin (TN)
Product
  Generic
TRETINOIN (A-S Medication Solutions), TRETINOIN (A-S Medication Solutions), TRETINOIN (Actavis Pharma), TRETINOIN (American Health Packaging), TRETINOIN (AvKARE), TRETINOIN (Dispensing Solutions), TRETINOIN (Glenmark Pharmaceuticals), TRETINOIN (Mylan Pharmaceuticals), TRETINOIN (OMP), TRETINOIN (Oceanside Pharmaceuticals), TRETINOIN (Oceanside Pharmaceuticals), TRETINOIN (Paddock Laboratories), TRETINOIN (Par Pharmaceutical), TRETINOIN (Preferred Pharmaceuticals), TRETINOIN (Rebel Distributors Corp), TRETINOIN (Rebel Distributors Corp), TRETINOIN (Rebel Distributors Corp), TRETINOIN (Rouses Point), TRETINOIN GEL (Spear Dermatology Products), TRETINOIN GEL MICROSPHERE (Spear Dermatology Products), TRETINOIN (Spear Dermatology Products), REFISSA (Suneva Medical), REFISSA (Suneva Medical), TRETINOIN (Teva Pharmaceuticals USA), TRETINOIN (EMOLLIENT) (ZO Skin Health), REFISSA TRETINOIN (EMOLLIENT) (ZO Skin Health)
Formula
C20H28O2
Exact mass
300.2089
Mol weight
300.4351
Structure
Mol fileKCF fileDB search
Simcomp SIMCOMP
Class
Other
 DG01604  Retinol derivative
Remark
Same as: C00777
Therapeutic category: 4291
ATC code: D10AD01 L01XX14
Chemical structure group: DG00433
Product (DG00433): D00094<JP/US> D01516<JP>
Product (mixture): D11084<US>
Efficacy
Antineoplastic, Keratolytic, Retinoic acid receptor (RAR) agonist
  Disease
Acne vulgaris [DS:H01445]
Comment
Vesanoid (TN): discontinued in FDA
Target
PML-RARA [HSA:5371 5914] [KO:K10054 K08527]
NR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]
  Pathway
hsa04659  Th17 cell differentiation
hsa05200  Pathways in cancer
hsa05202  Transcriptional misregulation in cancer
hsa05221  Acute myeloid leukemia
Interaction
Drug interaction
Structure map
map07223  Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D10 ANTI-ACNE PREPARATIONS
   D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
    D10AD Retinoids for topical use in acne
     D10AD01 Tretinoin
      D00094  Tretinoin (JAN/USP/INN) <JP/US>
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XX Other antineoplastic agents
     L01XX14 Tretinoin
      D00094  Tretinoin (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Retinoids
   Tretinoin
    D00094  Tretinoin (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4291  Other Antitumors
     D00094  Tretinoin (JAN/USP/INN)
Target-based classification of drugs [BR:br08310]
 Nuclear receptors
  Thyroid hormone like receptors
   Retinoic acid receptor (RAR)
    NR1B (RAR)
     D00094  Tretinoin (JAN/USP/INN) <JP/US>
    PML-RARA
     D00094  Tretinoin (JAN/USP/INN) <JP/US>
Antineoplastics [br08340.html]
 D00094
Pharmacogenomic biomarkers [br08341.html]
 Companion diagnostics
  D00094
BRITE hierarchy
Other DBs
CAS: 302-79-4
PubChem: 7847162
ChEBI: 15367
ChEMBL: CHEMBL38
DrugBank: DB00755
PDB-CCD: REA[PDBj]
LigandBox: D00094
NIKKAJI: J1.518K
LinkDB All DBs
KCF data Show

ATOM        22
            1   C1x C    14.4200  -19.8100
            2   C1x C    14.4200  -21.2100
            3   C1x C    15.6324  -21.9100
            4   C2y C    16.8449  -21.2100
            5   C2y C    16.8449  -19.8100
            6   C1z C    15.6324  -19.1100
            7   C1a C    16.4540  -17.9930
            8   C1a C    14.6889  -18.0557
            9   C1a C    18.0760  -21.9210
            10  C2b C    18.0760  -19.0990
            11  C2b C    19.2812  -19.7947
            12  C2c C    20.4635  -19.1119
            13  C2b C    21.6575  -19.8012
            14  C1a C    20.4635  -17.7102
            15  C2b C    22.8454  -19.1152
            16  C2b C    24.0365  -19.8029
            17  C2c C    25.2259  -19.1161
            18  C2b C    26.4162  -19.8034
            19  C6a C    27.6061  -19.1163
            20  O6a O    28.7962  -19.8035
            21  C1a C    25.2260  -17.7102
            22  O6a O    27.6061  -17.7102
BOND        22
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 1
            7     6   7 1
            8     6   8 1
            9     4   9 1
            10    5  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14   12  14 1
            15   13  15 1
            16   15  16 2
            17   16  17 1
            18   17  18 2
            19   18  19 1
            20   19  20 1
            21   17  21 1
            22   19  22 2

» Japanese version   » Back

DBGET integrated database retrieval system